172 related articles for article (PubMed ID: 23569071)
1. Meeting report--workshop on virus removal by filtration: trends and new developments.
Willkommen H; Blümel J; Brorson K; Chen D; Chen Q; Gröner A; Kreil TR; Robertson JS; Ruffing M; Ruiz S
PDA J Pharm Sci Technol; 2013; 67(2):98-104. PubMed ID: 23569071
[TBL] [Abstract][Full Text] [Related]
2. Meeting Report: PDA Virus and TSE Safety Forum.
Willkommen H; Blümel J; Brorson K; Chen D; Chen Q; Gröner A; Kreil TR; Robertson JS; Ruffing M; Ruiz S
PDA J Pharm Sci Technol; 2013; 67(2):81-97. PubMed ID: 23569070
[TBL] [Abstract][Full Text] [Related]
3. Meeting Report: 2013 PDA Virus & TSE Safety Forum.
Willkommen H; Blümel J; Brorson K; Chen D; Chen Q; Gröner A; Hubbard BR; Kreil TR; Ruffing M; Ruiz S; Scott D; Silvester G
PDA J Pharm Sci Technol; 2014; 68(3):193-214. PubMed ID: 25188343
[TBL] [Abstract][Full Text] [Related]
4. Achieving a Successful Scale-Down Model and Optimized Economics through Parvovirus Filter Validation using Purified TrueSpikeTM Viruses.
De Vilmorin P; Slocum A; Jaber T; Schaefer O; Ruppach H; Genest P
PDA J Pharm Sci Technol; 2015; 69(3):440-9. PubMed ID: 26048749
[TBL] [Abstract][Full Text] [Related]
5. Use of MMV as a Single Worst-Case Model Virus in Viral Filter Validation Studies.
Gefroh E; Dehghani H; McClure M; Connell-Crowley L; Vedantham G
PDA J Pharm Sci Technol; 2014; 68(3):297-311. PubMed ID: 25188350
[TBL] [Abstract][Full Text] [Related]
6. Integration of Planova filters in manufacturing processes of biologicals improve the virus safety effectively: A review of publicly available data.
Gröner A
Biotechnol Prog; 2024; 40(1):e3398. PubMed ID: 37985214
[TBL] [Abstract][Full Text] [Related]
7. Achieving high mass-throughput of therapeutic proteins through parvovirus retentive filters.
Bolton GR; Basha J; Lacasse DP
Biotechnol Prog; 2010; 26(6):1671-7. PubMed ID: 20859931
[TBL] [Abstract][Full Text] [Related]
8. Meeting report-workshop on spike characterizations and virus removal by filtration: trends and new developments.
Willkommen H; Blümel J; Brorson K; Chen D; Chen Q; Gröner A; Hubbard BR; Kreil TR; Ruffing M; Ruiz S; Scott D; Silvester G
PDA J Pharm Sci Technol; 2014; 68(3):215-20. PubMed ID: 25188344
[TBL] [Abstract][Full Text] [Related]
9. A novel approach to achieving modular retrovirus clearance for a parvovirus filter.
Stuckey J; Strauss D; Venkiteshwaran A; Gao J; Luo W; Quertinmont M; O'Donnell S; Chen D
Biotechnol Prog; 2014; 30(1):79-85. PubMed ID: 24123923
[TBL] [Abstract][Full Text] [Related]
10. Improving viral filtration capacity in biomanufacturing processes using aggregate binding properties of polyamide-6,6.
Stanevich V; Pachalla A; Nunez B; McInnes M; Nieder C; Schreffler J
Biotechnol Bioeng; 2021 Mar; 118(3):1105-1115. PubMed ID: 33241852
[TBL] [Abstract][Full Text] [Related]
11. Meeting Report: 2015 PDA Virus & TSE Safety Forum.
Willkommen H; Blümel J; Brorson K; Chen D; Chen Q; Gröner A; Kreil TR; Ruffing M; Ruiz S; Scott D; Silvester G
PDA J Pharm Sci Technol; 2016; 70(2):177-88. PubMed ID: 27020643
[TBL] [Abstract][Full Text] [Related]
12. Limits in virus filtration capability? Impact of virus quality and spike level on virus removal with xenotropic murine leukemia virus.
Roush DJ; Myrold A; Burnham MS; And JV; Hughes JV
Biotechnol Prog; 2015; 31(1):135-44. PubMed ID: 25395156
[TBL] [Abstract][Full Text] [Related]
13. Twenty plus Years of Data Demonstrating Virus Filtration as an Effective and Robust Step for Large Virus Removal.
Stanley B; Holmes V; Manzari R; Romanowski C; Tessarz A; Ruppach H; Schreffler J
PDA J Pharm Sci Technol; 2022; 76(1):1-8. PubMed ID: 33990425
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic failure mode investigation and resolution of parvovirus retentive filters.
LaCasse D; Lute S; Fiadeiro M; Basha J; Stork M; Brorson K; Godavarti R; Gallo C
Biotechnol Prog; 2016 Jul; 32(4):959-70. PubMed ID: 27160325
[TBL] [Abstract][Full Text] [Related]
15. Choice of parvovirus model for validation studies influences the interpretation of the effectiveness of a virus filtration step.
Nowak T; Popp B; Roth NJ
Biologicals; 2019 Jul; 60():85-92. PubMed ID: 31105022
[TBL] [Abstract][Full Text] [Related]
16. Validation and implementation of Planova™ BioEX virus filters in the manufacture of a new liquid intravenous immunoglobulin in China.
Ma S; Pang GL; Shao YJ; Hongo-Hirasaki T; Shang MX; Inouye M; Jian CY; Zhu MZ; Yang HH; Gao JF; Xi ZY; Song DW
Biologicals; 2018 Mar; 52():37-43. PubMed ID: 29434001
[TBL] [Abstract][Full Text] [Related]
17. Impact of virus preparation quality on parvovirus filter performance.
Slocum A; Burnham M; Genest P; Venkiteshwaran A; Chen D; Hughes J
Biotechnol Bioeng; 2013 Jan; 110(1):229-39. PubMed ID: 22766979
[TBL] [Abstract][Full Text] [Related]
18. Removal of viruses from human intravenous immune globulin by 35 nm nanofiltration.
Troccoli NM; McIver J; Losikoff A; Poiley J
Biologicals; 1998 Dec; 26(4):321-9. PubMed ID: 10403036
[TBL] [Abstract][Full Text] [Related]
19. A survey of quality attributes of virus spike preparations used in clearance studies.
Miesegaes G; Lute S; Dement-Brown J; Kaushal S; Strauss D; Chen D; Brorson K
PDA J Pharm Sci Technol; 2012; 66(5):420-33. PubMed ID: 23035026
[TBL] [Abstract][Full Text] [Related]
20. Virus filter scalability: Demonstration of consistent viral clearance across laboratory and manufacturing scales.
Buesing B; Schwartz A; Shah A; Sohka T; Hirotomi N; Strauss D
Biologicals; 2021 Jul; 72():27-32. PubMed ID: 34226123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
